PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
foxa3 | dr11_v1_chr18_-_46354269_46354269 | 0.62 | 2.9e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_23978978 Show fit | 33.83 |
ENSDART00000058964
ENSDART00000135084 |
apolipoprotein A-II |
|
chr2_+_10134345 Show fit | 23.15 |
ENSDART00000100725
|
alpha-2-HS-glycoprotein 2 |
|
chr5_+_32345187 Show fit | 20.76 |
ENSDART00000147132
|
complement component 9 |
|
chr5_-_16351306 Show fit | 20.35 |
ENSDART00000168643
|
|
|
chr5_+_28830643 Show fit | 19.55 |
ENSDART00000051448
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
chr5_+_28830388 Show fit | 18.81 |
ENSDART00000149150
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
chr20_+_6142433 Show fit | 18.45 |
ENSDART00000054084
ENSDART00000136986 |
transthyretin (prealbumin, amyloidosis type I) |
|
chr5_+_28857969 Show fit | 17.02 |
ENSDART00000149850
|
si:ch211-186e20.2 |
|
chr11_+_13223625 Show fit | 17.02 |
ENSDART00000161275
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11b |
|
chr21_-_1625976 Show fit | 16.39 |
ENSDART00000066621
|
vitelline membrane outer layer 1 homolog b |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 157.9 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.4 | 35.8 | GO:0055113 | epiboly involved in gastrulation with mouth forming second(GO:0055113) |
6.9 | 20.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.3 | 17.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
1.7 | 16.7 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.3 | 16.6 | GO:0006414 | translational elongation(GO:0006414) |
2.3 | 16.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 13.8 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.2 | 13.7 | GO:0006096 | glycolytic process(GO:0006096) |
1.9 | 13.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 203.6 | GO:0005615 | extracellular space(GO:0005615) |
6.9 | 20.8 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 20.6 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 20.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.4 | 18.4 | GO:0031941 | filamentous actin(GO:0031941) |
2.4 | 16.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.2 | 13.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 12.9 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 11.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 11.0 | GO:0005643 | nuclear pore(GO:0005643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 137.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.0 | 39.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.7 | 30.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 28.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 22.7 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 18.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
4.6 | 18.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 18.4 | GO:0051393 | muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
4.3 | 17.0 | GO:0015432 | canalicular bile acid transmembrane transporter activity(GO:0015126) bile acid-exporting ATPase activity(GO:0015432) |
2.3 | 13.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 37.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 32.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.0 | 16.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 13.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 12.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 7.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 6.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 4.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 4.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.5 | PID IGF1 PATHWAY | IGF1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 34.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 31.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.1 | 23.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.9 | 18.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.1 | 16.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 13.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
2.7 | 13.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.0 | 13.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 11.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 10.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |